STOCK TITAN

Itron (ITRI) SVP sells 255 shares under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

ITRON, INC. executive Donald L. Reeves III, SVP, Outcomes, reported an open-market sale of 255 shares of common stock on May 21, 2026 at $80.88 per share. The sale was made under a Rule 10b5-1 trading plan adopted on September 11, 2025. After this transaction, he directly holds 29,419 shares of Itron stock, indicating a relatively small, pre-planned reduction in his position.

Positive

  • None.

Negative

  • None.
Insider Reeves Donald L. III
Role SVP, Outcomes
Sold 255 shs ($21K)
Type Security Shares Price Value
Sale Common Stock 255 $80.88 $21K
Holdings After Transaction: Common Stock — 29,419 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares sold 255 shares Open-market sale of common stock on May 21, 2026
Sale price per share $80.88 per share Price for the 255-share open-market sale
Shares owned after transaction 29,419 shares Direct holdings of Donald L. Reeves III after sale
Transaction code Code S Sale in open market or private transaction
Trading plan adoption date September 11, 2025 Rule 10b5-1 Trading Plan used for this sale
Rule 10b5-1 Trading Plan regulatory
"Represents number of shares sold under a Rule 10b5-1 Trading Plan adopted by Mr. Reeves on September 11, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
open-market sale financial
"transaction_action: "open-market sale" for 255 shares of Common Stock."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"INSIDER FILING DATA (Form 4) reports this sale of Itron common stock."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Reeves Donald L. III

(Last)(First)(Middle)
2111 N. MOLTER ROAD

(Street)
LIBERTY LAKE WASHINGTON 99019

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ITRON, INC. [ ITRI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Outcomes
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/21/2026S255(1)D$80.8829,419D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents number of shares sold under a Rule 10b5-1 Trading Plan adopted by Mr. Reeves on September 11, 2025.
/s/ Christopher E. Ware, attorney-in-fact05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Itron (ITRI) SVP Donald L. Reeves III report?

Donald L. Reeves III reported selling 255 shares of Itron common stock. The open-market sale occurred on May 21, 2026 at a price of $80.88 per share, as disclosed in a Form 4 insider trading report.

How many Itron (ITRI) shares does Donald L. Reeves III hold after the sale?

After the reported transaction, Donald L. Reeves III directly holds 29,419 shares of Itron common stock. This post-transaction balance reflects his remaining ownership following the 255-share open-market sale disclosed in the Form 4 filing.

Was the Itron (ITRI) insider trade made under a Rule 10b5-1 trading plan?

Yes. The footnote states the 255 shares were sold under a Rule 10b5-1 Trading Plan adopted by Donald L. Reeves III on September 11, 2025. Such pre-arranged plans schedule trades in advance to help manage insider trading compliance.

What type of transaction did the Itron (ITRI) Form 4 disclose for Reeves?

The Form 4 discloses an open-market sale of common stock coded as “S.” It involved 255 non-derivative shares sold at $80.88 each, with Reeves’ ownership listed as direct, meaning the shares are held in his own name.

Does this Itron (ITRI) Form 4 show a major change in Reeves’ holdings?

The sale represents only 255 shares compared with 29,419 shares held afterward. That indicates a relatively small change in his position, and the transaction was executed under a pre-established Rule 10b5-1 trading plan.